User Tools
1997
The Food and Drug Administration (FDA) approved Deep brain stimulation DBS as a treatment for essential tremor in 1997, for Parkinson's disease in 2002, dystonia in 2003, and obsessive compulsive disorders, in 2009. DBS is also used in research studies to treat chronic pain, PTSD, and has been used to treat various affective disorders, including major depression; neither of these applications of DBS have yet been FDA-approved. While DBS has proven effective for some patients, potential for serious complications and side effects exists.
Interhemispheric acute subdural hematoma were first described by Aring and Evans 1) in 1940 and only about 100 cases have been reported till 1997 2) 3) 4).
1)
Aring CD, Evans JP. Aberrant location of subdural hematoma. Arch Neurol Psychiatry. 1940;44:1296–306.
2)
Sadrolhefazi A, Bloomfield SM. Interhemispheric and bilateral chronic subdural hematoma. Neurosurg Clin N Am. 2000;11:455–63.
3)
Houtteville JP, Toumi K, Theron J, Derlon JM, Benazza A, Hubert P. Interhemispheric subdural haematomas: seven cases and review of the literature. Br J Neurosurg. 1988;2:357–67. doi: 10.3109/02688698809001007.
4)
Rapanà A, Lamaida E, Pizza V, Lepore P, Caputi F, Graziussi G. Inter-hemispheric scissure, a rare location for a traumatic subdural hematoma, case report and review of the literature. Clin Neurol Neurosurg. 1997;99:124–9. doi: 10.1016/S0303-8467(96)00585-9.
1997.txt · Last modified: 2018/10/22 08:12 by administrador
Page Tools
Except where otherwise noted, content on this wiki is licensed under the following license: CC Attribution-Share Alike 4.0 International
